This drug significantly reduced cholesterol from 40 percent to 72 percent when given at two-week intervals. It was also given at four-week intervals but the effects were not nearly as significant. However, “Six patients, all receiving REGN727, stopped the therapy due to adverse events which included headache, injection site reactions, and diarrhea” (Curley, Ann, CNN, 2012). Those side effects would likely scare anyone. That is why the government needs to step in and offer a grant for these companies to dig deeper into their studies and come up with something that has less side effects.
Case Study Amgen Inc. is a pharmaceutical company based out of California. Amgen developed a drug called Aranesp to treat amnesia associated with chronic renal failure. In 2009, fifteen states filed lawsuits against them for allegations of participating in Medicaid kickback schemes. The law suits alleged that Amgen Inc. continued to market and sell Aranesp despite several complaints concerning a link between increase risk of death and heart attacks in kidney patients after using the drug. Also, Amgen encouraged doctors to switch Medicare and Medicaid patients to Aranesp, then bill Medicare and Medicaid for Aranesp.
Companies’ off-label drugs so that they can make a great deal more profit in the end. This is because instead of just selling and having one drug on the market for one sole purpose, they can have one drug on the market that can be used for several other treatments. Although they cannot legally promote the off-label uses of their drugs to the doctors, some companies take the risk anyways for personal benefits. Take Pfizer for example; they had four off-label drugs out on the market that resulted in making their patients sicker and even causing death for the uses that they were prescribed. This cost Pfizer $2.3 billion dollars.
* Is the sample representative? Induction or inductive reasoning, sometimes called inductive logic, is the process of reasoning in which the premises of an argument are believed to support the conclusion but do not ensure it. It is used to ascribe properties or relations to types based on tokens (i.e., on one or a small number of observations or experiences); or to formulate laws based on limited observations of recurring phenomenal patterns. Deductive reasoning is dependent on its premises. That is, a false premise can possibly lead to a false result, and inconclusive premises will also yield an inconclusive conclusion.
Dangerous abbreviations may still be used by pharmacy professionals. • How might gaining an expertise of roots, prefixes, and abbreviations used in the pharmacy field assist you in your practice? Is there a situation when it would be inappropriate to use abbreviations? How might patient safety be affected by pharmacy personnel who understand roots, prefixes, suffixes, and abbreviations? 2.
A research program is trying to come up with different organizations to test humans. Using ideas from animal testing facilities and past human testing, they're trying to make a successful and safe place all in one. There are quotes from different medical professionals that seem to be important to note. "The Risks of Medical Research." New York Times 6 Aug. 2001: A12.
However, after legalization, these drugs would be much more widely and easily available. Not only will they be more available for adults, but they will also be available for the American youth. Legalization of illegal drugs could cause a pediatric pandemic of drug abuse and addiction. For example, 87% of high school seniors report using alcohol, more than half in the past month. Opposite the high rates of alcohol and tobacco use by teenagers, only 18% of seniors use illicit drugs, which are illegal for the entire society.
FDA can issue warnings to companies that violate rules and regulations such as cGMPs. Gulf Pharmaceutical Industries (2/23/12) and Laboratories Jaloma S.A. de C.V. (3/9/12) are two companies that received warning letters in 2012 from the FDA’s Office of manufacturing and Product Quality.12 Gulf Pharmaceutical Industries was cited for adulterated products due to cGMP violations that require manufactures to take specific steps to prevent contaminantion. The warning letter stated the specific CFR code violated, a request for corrective actions and supporting documentation, and a specific deadline to respond to the letter. In addition, the FDA warned the company that their products will be not be accepted into the United States until there is proof of cGMP compliance and corrective actions are implemented. Laboratories Jaloma S.A. de C.V. had a similar warning letter for noncompliance to standards and cGMPs.
The mix should have a sufficient initial impact and long term viability on sales so as to recover CSP initial investment of $400 million in 10 years. In 2005 the overweight U.S. population was about 209 million Americans. Competitors in the weight loss drugs included Alli, which was an over-the-counter drug with FDA approval, all other competitors were herbal or dietary supplements thus not regulated by any governing body. The legal and social climate at the time was not in favor of the drug industry. As a whole this industry was tagged with deceptive advertising because side effects where not known until after the product reached the market, thus this translated to low credibility from consumer’s and the professional medical community perspective.
This has led to tax revenue of over 2 million dollars in the month of January 2014 alone. This also suggests there is a large demand for legal advice in an emerging industry that promises to be generously profitable. The supporters also argued the implications of these rules go far beyond a lawyer freely advising the owner of a marijuana dispensary, to dealing with the bank that gives the owner a loan or even settling a divorce in which one parent requests that another refrain from smoking marijuana before picking up the kids. They said pot-related legal issues had come up with homeowners’ associations and criminal matters — all without the lawyers ever knowing what was safe ground. “It’s not just marijuana entrepreneurs,” was said.